---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-034589"
form_type: "8-K"
ticker: "NVNO"
cik: "0001661053"
company_name: "enVVeno Medical Corp"
filed_at: "2022-12-06T23:59:59+00:00"
generated_at: "2026-06-21T08:56:31.779089+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "high"
source: SEC EDGAR
---

# enVVeno Medical shareholders elect Berman and Jenusaitis as Class II directors; ratify Marcum as auditor

## Summary
- Robert A. Berman re-elected with 2,378,488 votes for, 697,978 withheld; 2,373,744 broker non-votes.
- Matthew M. Jenusaitis re-elected with 1,869,004 votes for, 1,207,462 withheld; 2,373,744 broker non-votes.
- Ratification of Marcum LLP as independent auditor for FY 2022 passed: 5,445,167 for, 4,108 against, 935 abstain.
- Annual meeting held Nov 30, 2022; 5,450,210 of 9,471,932 entitled shares present.

## SEC filing metadata
- accession: 0001493152-22-034589
- form_type: 8-K
- ticker: NVNO
- cik: 0001661053
- company_name: enVVeno Medical Corp
- filed_at: 2022-12-06T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1661053/000149315222034589/0001493152-22-034589-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1661053/000149315222034589/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-034589
- JSON: https://secwatch.observer/filing/0001493152-22-034589.json
- Plain text: https://secwatch.observer/filing/0001493152-22-034589.txt

## Key facts
- Shareholder Votes
  enVVeno Medical Corp shareholders approved Election of Class I directors Mr. Robert A. Berman and Mr. Matthew M. Jenusaitis at the 2022-11-30 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2022-11-30
  source text: Proposal No. 1 – Election of Class I directors Mr. Robert A. Berman and Mr. Matthew M. Jenusaitis were elected as a Class II directors to serve for a three-year term that expires at the 2025 annual meeting of stockholders or until their successors are elected and qualified or until their earlier death, incapacity, removal or resignation. The voting results were as follows: Nominee Shares Voted For Shares Withheld Broker Non-Votes Mr. Robert A. Berman 2,378,488 697,978 2,373,744 Mr. Matthew M. Jenusaitis 1,869,004 1,207,462 2,373,744
  evidence_url: https://www.sec.gov/Archives/edgar/data/1661053/000149315222034589/0001493152-22-034589-index.htm
- Shareholder Votes
  enVVeno Medical Corp shareholders approved Ratification of the appointment of Marcum LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022 at the 2022-11-30 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2022-11-30
  source text: Proposal No. 2 – Ratification of the appointment of independent registered public accounting firm The appointment of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022 was ratified. The voting results were as follows: Shares Voted For Shares Voted Against Shares Abstaining Broker Non-Vote 5,445,167 4,108 935 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1661053/000149315222034589/0001493152-22-034589-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.